Search Results 451-460 of 17377 for alopecia

1. A Study to Compare the Effectiveness and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRMM) - Mayo Clinic

   Recovery to Grade 1 or baseline of any non-hematologic toxicities due to prior treatments, excluding alopecia and Grade 2 peripheral neuropathy. Exclusion ...

2. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   Relevant toxicities of prior therapies must have resolved to ≤Grade 1, except for oxaliplatin-related neuropathy or alopecia;; Participant with myocardial ...

3. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   ... alopecia) prior to initiation of study drug administration; Adequate hematologic and organ function as confirmed by laboratory values; Last dose of any prior ...

4. TheraSphere With and Without Durvalumab and Tremelimumab for HCC - Mayo Clinic

   Patients with vitiligo or alopecia 2. Patients with hypothyroidism (e.g. following Hashimoto's syndrome) stable on hormone replacement therapy 3. Any ...

5. Vulvar cancer - Doctors and departments - Mayo Clinic

   Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

6. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

   Recovery to Grade ≤ 1 for any non-laboratory toxicity resulting from previous anticancer therapy prior to first dose of ALPN-202 (except alopecia, hearing ...

7. A First in Man Trial for Patients With Cancer - Mayo Clinic

   Recovery from adverse effects of prior therapy at time of enrollment to o ≤ Grade 1 (excluding alopecia); Agreement to forego any other chemotherapy ...

8. Mayo Clinic Radio: Dermatology topics / autoimmune disease research / hereditary cancers

   Your skin is not only the biggest organ in your body, it's also the most visible. Dermatology focuses on problems with skin, hair and nails.

9. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant - Mayo Clinic

   Exception to this criterion: participant with any grade of alopecia are allowed to enter in the study. Participant with Child Pugh score B or C. Participant ...

10. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

    ... alopecia, related to anticancer therapy prior to the first dose of study drug; Major medical conditions that might affect EAP participation (e.g. ...